Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Condition or disease
Brain Tumor, PrimaryBrain Metastases, Adult
Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients diagnosed with primary or metastatic brain tumors and treated in the Department of Radiation Oncology at Duke
Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate)
Participation in other blood repository research protocols at Duke